\-\ Texto\\:\\ \ \(0\)\
\-\ bp\\:\\ 111\\/63\\,\\ hr\\:\\ 98\\,\\ rr\\:\\ 18\\,\\ t\\:\\ 97\\.6\\ \\¬\\∞f\\,\\ ht\\:\\ 63\\ in\\,\\ wt\\:\\ 158\\ lbs\\,\\ bmi\\:\\ 27\\.99\\.\ \(0\)\
\-\ no\\ focal\\ neurological\\ findings\\ found\\ on\\ exam\ \(0\)\
\-\ csf\\:\\ large\\ amount\\ of\\ rbc\\ with\\ xanthochromia\ \(0\)\
\-\ esr\\:\\ 56\\ mm\\/hour\ \(0\)\
\-\ no\\ proteinuria\\ on\\ ua\ \(0\)\
\-\ otherwise\\ normal\\ exam\\ and\\ labs\ \(0\)\
\-\ cerebral\\ vasculitis\\ is\\ a\\ highly\\ treatable\\ condition\\;\\ there\\ currently\\ is\\ no\\ standard\\ management\\ that\\ has\\ been\\ established\\,\\ but\\ most\\ authors\\ agree\\ that\\ acute\\-phase\\ treatment\\ includes\\ cessation\\ of\\ vasoconstrictors\\,\\ treatment\\ of\\ associated\\ conditions\\,\\ vasospasm\\ treatment\\ \\(calcium\\ channel\\ antagonists\\)\\,\\ corticosteroids\\,\\ headache\\ relief\\,\\ blood\\ pressure\\ control\\,\\ and\\ stroke\\,\\ cerebral\\ edema\\,\\ and\\ seizure\\ treatment\\ as\\ needed\\.\\ \\ a\\ high\\ dose\\ intravenous\\ steroids\\ \\‚\\Ä\\ì\\ probably\\ best\\ as\\ intravenous\\ methyl\\ prednisolone\\ 1\\ gram\\ daily\\ for\\ 3\\ days\\.\\ \\ other\\ treatments\\ including\\ azathioprine\\ \\(2\\ mg\\/kg\\/day\\)\\ for\\ 10\\ months\\,\\ methotrexate\\ 10\\‚\\Ä\\ì25\\ mg\\ on\\ a\\ weekly\\ basis\\,\\ intravenous\\ immunoglobulin\\ \\(0\\.4\\ mg\\/kg\\/day\\ for\\ 5\\ days\\)\\,\\ plasmapheresis\\,\\ and\\ campath\\-1h\\ may\\ be\\ used\\ depending\\ upon\\ the\\ etiology\\.\\ \ \(0\)\
\-\ references\\:\ \(0\)\
\-\ \\‚\\Ä\\¢\\ calado\\ s\\,\\ viana\\-baptista\\ m\\.\\ \\‚\\Ä\\úbenign\\ cerebral\\ angiopathy\\;\\ postpartum\\ cerebral\\ angiopathy\\:\\ characteristics\\ and\\ treatment\\‚\\Ä\\ù\\.\\ curr\\ treat\\ options\\ cardiovasc\\ med\\.\\ 2006\\ may\\;8\\(3\\)\\:201\\-12\\.\ \(0\)\
\-\ \\‚\\Ä\\¢\\ joseph\\ f\\,\\ scolding\\ n\\.\\ \\‚\\Ä\\úcerebral\\ vasculitis\\ a\\ practical\\ approach\\‚\\Ä\\ù\\ practical\\ neurology\\ 2002\\,\\ 2\\,\\ 80\\‚\\Ä\\ì93\\.\\ pn\\.bmj\\.com\\/cgi\\/reprint\\/2\\/2\\/80\\.pdf\ \(0\)\
\-\ ct\\:\\ \\ axial\\ noncontrast\\ ct\\ of\\ the\\ brain\\ showed\\ an\\ acute\\ sah\\ in\\ the\\ right\\ frontal\\ lobe\\ brain\\.\\ \\ \ \(0\)\
\-\ cerebral\\ angiogram\\:\\ \\ lateral\\ projection\\ of\\ the\\ right\\ cerebral\\ angiogram\\ demonstrated\\ irregular\\ variable\\ caliber\\ in\\ cortical\\ vessels\\ in\\ the\\ right\\ mca\\ distribution\\.\\ \\ \ \(0\)\
\-\ mri\\/mra\\:\\ \\ diffusion\\ weight\\ image\\,\\ apparent\\ diffusion\\ coefficient\\ mri\\,\\ and\\ t2\\-weighted\\ images\\ of\\ brain\\ demonstrate\\ an\\ acute\\ infarct\\ in\\ the\\ right\\ mid\\-posterior\\ cerebellar\\ in\\ the\\ superior\\ cerebellar\\ vascular\\ territory\\.\\ \\ \ \(0\)\
\-\ axial\\ flair\\ mri\\ of\\ the\\ brain\\ showed\\ multiple\\ nonspecific\\ small\\ foci\\ of\\ increased\\ flair\\ signal\\ within\\ the\\ anterior\\ aspects\\ of\\ the\\ external\\ capsule\\ bilaterally\\.\\ \\ \ \(0\)\
\-\ 3d\\ time\\ of\\ flight\\ mra\\ of\\ the\\ cerebral\\ arteries\\ demonstrated\\ mca\\ cortical\\ vessel\\ caliber\\ variation\\.\ \(0\)\
\-\ postpartum\\ cerebral\\ angiopathy\ \(4\)\
\-\ postpartum\\ cerebral\\ angiopathy\\ \ \(2\)\
\-\ preeclampsia\\ \ \(1\)\
\-\ pseudoanyeurysm\\ \ \(0\)\
\-\ primary\\ cerebral\\ vasculitis\\ \ \(0\)\
\-\ other\\ secondary\\ cerebral\\ vasculitis\\:\\ \ \(0\)\
\-\ \\‚\\Ä\\¢\\ polyarteritis\\ nodosa\\ \ \(0\)\
\-\ \\‚\\Ä\\¢\\ giant\\ cell\\ arteritis\\ \ \(0\)\
\-\ \\‚\\Ä\\¢\\ takayasu\\‚\\Ä\\ôs\\ arteritis\\ \ \(0\)\
\-\ \\‚\\Ä\\¢\\ wegener\\‚\\Ä\\ôs\\ granulomatosis\\ \ \(0\)\
\-\ \\‚\\Ä\\¢\\ sle\\ \ \(0\)\
\-\ \\‚\\Ä\\¢\\ ra\\ \ \(0\)\
\-\ \\‚\\Ä\\¢\\ behcet\\‚\\Ä\\ôs\\ syndrome\\ \ \(0\)\
\-\ \\‚\\Ä\\¢\\ lyme\\ disease\\ \ \(0\)\
\-\ \\‚\\Ä\\¢\\ illicit\\ drugs\\ \ \(0\)\
\-\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\&\\#61607\\;\\	cocaine\\ \ \(1\)\
\-\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\&\\#61607\\;\\	heroin\\ \ \(1\)\
\-\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\&\\#61607\\;\\	amphetamines\\ \ \(1\)\
\-\ \\‚\\Ä\\¢\\ sarcoidosis\ \(1\)\
\-\ 34\\-year\\-old\\ african\\ american\\ g1p1\\ female\\ with\\ no\\ significant\\ medical\\ history\\ presents\\ to\\ the\\ er\\ four\\ days\\ postpartum\\ complaining\\ of\\ the\\ \\‚\\Ä\\úworst\\ headache\\ of\\ her\\ life\\‚\\Ä\\ù\\ on\\ the\\ right\\-sided\\ of\\ her\\ head\\.\ \(0\)\
\-\ postpartum\\ cerebral\\ angiopathy\\ is\\ a\\ rare\\ ailment\\ that\\ affects\\ females\\ who\\ are\\ otherwise\\ healthy\\ and\\ recently\\ had\\ a\\ normal\\ pregnancy\\ and\\ uncomplicated\\ delivery\\.\\ \\ like\\ primary\\ and\\ other\\ secondary\\ cerebral\\ vasculitis\\,\\ postpartum\\ cerebral\\ angiopathy\\ may\\ cause\\ ischemic\\ or\\ hemorrhagic\\ stroke\\,\\ and\\ neurological\\ deficits\\.\\ \\ more\\ commonly\\,\\ secondary\\ cerebral\\ angiopathy\\ occurs\\ in\\ the\\ setting\\ of\\ other\\ medical\\ conditions\\ such\\ as\\ infections\\,\\ systemic\\ vasculitis\\ \\(wegener\\‚\\Ä\\ôs\\ granulomatosis\\ \\&\\ polyarteritis\\)\\,\\ connective\\ tissue\\ diseases\\ \\(systemic\\ lupus\\ erythematosus\\ \\&\\ rheumatoid\\ arthritis\\)\\,\\ medications\\,\\ illicit\\ drugs\\,\\ carcinomas\\ \\(lymphoma\\ \\&\\ leukemia\\)\\,\\ and\\ behcet\\‚\\Ä\\ôs\\ disease\\.\\ \\ other\\ conditions\\,\\ therefore\\,\\ need\\ to\\ be\\ ruled\\ out\\ before\\ a\\ diagnosis\\ of\\ postpartum\\ cerebral\\ angiopathy\\ can\\ be\\ made\\ including\\ preeclampsia\\ \\/eclampsia\\.\\ \ \(0\)\
\-\ \\ \\ contrast\\ catheter\\ angiography\\ and\\ magnetic\\ resonance\\ imaging\\/angiography\\ \\(mri\\/mra\\)\\ are\\ the\\ typical\\ imaging\\ modalities\\ used\\ to\\ help\\ with\\ the\\ diagnosis\\ of\\ cerebral\\ vasculitis\\ although\\,\\ single\\ photon\\ emission\\ computed\\ tomography\\ \\(spect\\)\\ and\\ indium\\-labelled\\ white\\ cell\\ nuclear\\ scanning\\ may\\ provide\\ some\\ benefit\\.\\ \\ definitive\\ diagnosis\\ of\\ cerebral\\ vasculitis\\ is\\ typically\\ made\\ by\\ biopsy\\ of\\ brain\\.\\ \ \(0\)\
\-\ \\ \\ in\\ this\\ patient\\ she\\ presented\\ to\\ the\\ er\\ with\\ the\\ \\‚\\Ä\\úworse\\ headache\\ of\\ her\\ life\\‚\\Ä\\ù\\ on\\ the\\ right\\ side\\ 4\\ days\\ postpartum\\.\\ \\ noncontrast\\ computed\\ tomography\\ \\(ct\\)\\ showed\\ subarachnoid\\ hemorrhage\\ \\(sah\\)\\ with\\ the\\ right\\ sylvian\\ fissure\\ and\\ the\\ sulci\\ of\\ the\\ right\\ frontal\\ lobe\\.\\ \\ further\\ vascular\\ studies\\ including\\ a\\ ct\\ angiogram\\ \\(cta\\)\\,\\ contrast\\ angiography\\,\\ and\\ mra\\ showed\\ no\\ evidence\\ of\\ an\\ intracerebral\\ aneurysm\\.\\ \\ the\\ patient\\ had\\ no\\ history\\ of\\ hypertension\\ and\\ was\\ not\\ hypertensive\\ during\\ the\\ headache\\.\\ \\ she\\ was\\ tested\\ several\\ times\\ throughout\\ pregnancy\\ with\\ no\\ evidence\\ of\\ elevated\\ blood\\ pressure\\,\\ proteinuria\\,\\ or\\ headaches\\ looking\\ for\\ preeclampsia\\.\\ \\ the\\ patient\\ had\\ an\\ elevated\\ erythrocyte\\ sedimentation\\ rate\\ \\(esr\\)\\ of\\ 56\\ mm\\/hour\\.\\ \\ \ \(0\)\
\-\ upon\\ further\\ investigation\\ the\\ patient\\ had\\ a\\ contrast\\ enhanced\\ angiogram\\ which\\ showed\\ irregular\\ variable\\ caliber\\ vessels\\ with\\ \\‚\\Ä\\úsausage\\ linked\\‚\\Ä\\ù\\ appearance\\ in\\ the\\ cortical\\ branches\\ of\\ both\\ the\\ middle\\ cerebral\\ arteries\\ with\\ a\\ more\\ prominence\\ on\\ the\\ right\\ side\\ as\\ opposed\\ to\\ the\\ left\\.\\ \\ the\\ mri\\ also\\ showed\\ and\\ acute\\ 5\\ mm\\ left\\ cerebellar\\ infarct\\ located\\ within\\ a\\ superior\\ cerebellar\\ artery\\ vascular\\ territory\\ and\\ multiple\\ nonspecific\\ small\\ foci\\ of\\ increased\\ flair\\ signal\\ within\\ the\\ anterior\\ aspects\\ of\\ the\\ external\\ capsule\\ bilaterally\\.\\ \\ \ \(0\)\
\-\ this\\ patient\\ had\\ several\\ classic\\ imaging\\ findings\\ of\\ cerebral\\ vasculopathy\\ of\\ small\\ vessel\\ ischemic\\ disease\\,\\ sah\\,\\ and\\ cortical\\ enhancement\\.\\ \\ she\\ had\\ no\\ known\\ significant\\ past\\ medical\\ history\\ including\\ autoimmune\\ disorders\\,\\ systemic\\ vasculitis\\,\\ or\\ connective\\ tissue\\ disorders\\.\\ \\ she\\ had\\ a\\ normal\\ uncomplicated\\ pregnancy\\ and\\ developed\\ her\\ first\\ symptoms\\ 4\\ days\\ postpartum\\ fitting\\ the\\ description\\ of\\ postpartum\\ cerebral\\ angiopathy\\.\\ \\ \ \(0\)\
\-\ the\\ patient\\ was\\ treated\\ with\\ oral\\ prednisolone\\ and\\ was\\ felt\\ that\\ a\\ brain\\ biopsy\\ was\\ not\\ necessary\\ in\\ this\\ case\\ to\\ make\\ the\\ definitive\\ diagnosis\\.\ \(0\)\
\-\ references\\:\ \(0\)\
\-\ \\‚\\Ä\\¢\\ brant\\ w\\,\\ helms\\ c\\.\\ \\‚\\Ä\\úfundamentals\\ of\\ diagnostic\\ radiology\\‚\\Ä\\ù\\ lippincott\\ williams\\ \\&\\ wilkins\\,\\ philadelphia\\,\\ pa\\ 2007\\.\ \(0\)\
\-\ \\‚\\Ä\\¢\\ singhal\\ a\\,\\ bernstein\\ r\\.\\ \\‚\\Ä\\úpostpartum\\ angiopathy\\ and\\ other\\ cerebral\\ vasoconstriction\\ syndromes\\‚\\Ä\\ù\\.\\ neurocrit\\ care\\.\\ 2005\\;3\\(1\\)\\:91\\-7\\.\ \(0\)\
\-\ \\‚\\Ä\\¢\\ wilhelm\\ k\\.\\ \\‚\\Ä\\úimaging\\ of\\ cerebral\\ vasculitis\\‚\\Ä\\ù\\ \\‚\\Ä\\úinternational\\ journal\\ of\\ stroke\\‚\\Ä\\ù\\ vol\\ 2\\(3\\)\\,\\ 184\\ \\‚\\Ä\\ì190\\.\ \(0\)\
\-\ \\‚\\Ä\\¢\\ amos\\ p\\.\\ postpartum\\ cerebral\\ angiopathy\\:\\ a\\ case\\ study\\.\\ j\\ neurosci\\ nurs\\.\\ 2007\\ feb\\;39\\(1\\)\\:9\\-12\\.\ \(0\)\
\-\ \\‚\\Ä\\¢\\ joseph\\ f\\,\\ scolding\\ n\\.\\ \\‚\\Ä\\úcerebral\\ vasculitis\\ a\\ practical\\ approach\\‚\\Ä\\ù\\ practical\\ neurology\\ 2002\\,\\ 2\\,\\ 80\\‚\\Ä\\ì93\\.\\ pn\\.bmj\\.com\\/cgi\\/reprint\\/2\\/2\\/80\\.pdf\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ cerebral\\:\\ 0\\.07173495717228877\ \(0\)\
\-\ postpartum\\:\\ 0\\.06907505417727389\ \(0\)\
\-\ angiopathy\\:\\ 0\\.06132838385742135\ \(0\)\
\-\ vasculitis\\:\\ 0\\.04482902035623299\ \(0\)\
\-\ \\‚\\Ä\\ú\\:\\ 0\\.029743717779861692\ \(0\)\
\-\ \\‚\\Ä\\ù\\:\\ 0\\.029576993038475156\ \(0\)\
\-\ \\‚\\Ä\\¢\\:\\ 0\\.024826881618946965\ \(0\)\
\-\ 61607\\:\\ 0\\.024647302210530752\ \(0\)\
\-\ practical\\:\\ 0\\.02330128263375568\ \(0\)\
\-\ preeclampsia\\:\\ 0\\.021575692829352438\ \(0\)\
\-\ \\&\\:\\ 0\\.019580349715740932\ \(0\)\
\-\ \\:\\:\\ 0\\.01790742951709348\ \(0\)\
\-\ sah\\:\\ 0\\.01707586641993743\ \(0\)\
\-\ mm\\/hour\\:\\ 0\\.0164315348070205\ \(0\)\
\-\ scolding\\:\\ 0\\.0164315348070205\ \(0\)\
\-\ 80\\‚\\Ä\\ì93\\:\\ 0\\.0164315348070205\ \(0\)\
\-\ pn\\.bmj\\.com\\/cgi\\/reprint\\/2\\/2\\/80\\.pdf\\:\\ 0\\.0164315348070205\ \(0\)\
\-\ showed\\:\\ 0\\.015667119857914427\ \(0\)\
\-\ angiogram\\:\\ 0\\.01540871275616879\ \(0\)\
\-\ prednisolone\\:\\ 0\\.01513955497373076\ \(0\)\
\-\ \\;\\:\\ 0\\.01510099674521971\ \(0\)\
\-\ mg\\/kg\\/day\\:\\ 0\\.01438379521956829\ \(0\)\
\-\ brain\\:\\ 0\\.014378480093025697\ \(0\)\
\-\ caliber\\:\\ 0\\.014067088881775127\ \(0\)\
\-\ cerebellar\\:\\ 0\\.013739495653470362\ \(0\)\
\-\ s\\:\\ 0\\.013704199443324811\ \(0\)\
\-\ \\,\\:\\ 0\\.013371513021823142\ \(0\)\
\-\ behcet\\:\\ 0\\.01309181538627855\ \(0\)\
\-\ polyarteritis\\:\\ 0\\.012555595307151281\ \(0\)\
\-\ stroke\\:\\ 0\\.01246638284420384\ \(0\)\
\-\ days\\:\\ 0\\.012204446860074452\ \(0\)\
\-\ mri\\/mra\\:\\ 0\\.012139670700787423\ \(0\)\
\-\ had\\:\\ 0\\.012028843182371815\ \(0\)\
\-\ \\‚\\Ä\\ô\\:\\ 0\\.011901336158646112\ \(0\)\
\-\ conditions\\:\\ 0\\.011885844079679391\ \(0\)\
\-\ intravenous\\:\\ 0\\.011856870770167146\ \(0\)\
\-\ proteinuria\\:\\ 0\\.01179983555298881\ \(0\)\
\-\ cortical\\:\\ 0\\.011612580990030985\ \(0\)\
\-\ including\\:\\ 0\\.011502026620663276\ \(0\)\
\-\ systemic\\:\\ 0\\.011430001692229705\ \(0\)\
\-\ other\\:\\ 0\\.01101382226674249\ \(0\)\
\-\ flair\\:\\ 0\\.010953435109083655\ \(0\)\
\-\ headache\\:\\ 0\\.010941231826899525\ \(0\)\
\-\ \\(\\:\\ 0\\.010771470288818051\ \(0\)\
\-\ territory\\:\\ 0\\.010756749275383178\ \(0\)\
\-\ \\)\\:\\ 0\\.010639891028716571\ \(0\)\
\-\ arteritis\\:\\ 0\\.010587183985158151\ \(0\)\
\-\ illicit\\:\\ 0\\.010507855719699071\ \(0\)\
\-\ pregnancy\\:\\ 0\\.010271728427205513\ \(0\)\
\-\ wegener\\:\\ 0\\.010155121330810854\ \(0\)\
\-\ granulomatosis\\:\\ 0\\.0099716356405718\ \(0\)\
\-\ neurology\\:\\ 0\\.009701026116164536\ \(0\)\
\-\ her\\:\\ 0\\.009578421839645612\ \(0\)\
\-\ connective\\:\\ 0\\.00937805925451675\ \(0\)\
\-\ \\#\\:\\ 0\\.009370978431335195\ \(0\)\
\-\ n\\:\\ 0\\.00925511802843698\ \(0\)\
\-\ mca\\:\\ 0\\.00925511802843698\ \(0\)\
\-\ aspects\\:\\ 0\\.009177442918650273\ \(0\)\
\-\ 2007\\:\\ 0\\.008996336211374136\ \(0\)\
\-\ uncomplicated\\:\\ 0\\.008962134648152893\ \(0\)\
\-\ she\\:\\ 0\\.00894235281063997\ \(0\)\
\-\ mra\\:\\ 0\\.008928549362966167\ \(0\)\
\-\ drugs\\:\\ 0\\.008799951280045475\ \(0\)\
\-\ 2002\\:\\ 0\\.008709009687930971\ \(0\)\
\-\ capsule\\:\\ 0\\.008622299500354282\ \(0\)\
\-\ noncontrast\\:\\ 0\\.008512624756602308\ \(0\)\
\-\ tomography\\:\\ 0\\.008512624756602308\ \(0\)\
\-\ variable\\:\\ 0\\.008486185548788784\ \(0\)\
\-\ computed\\:\\ 0\\.008409046282874796\ \(0\)\
\-\ 56\\:\\ 0\\.008384026673681618\ \(0\)\
\-\ approach\\:\\ 0\\.008359338459795279\ \(0\)\
\-\ f\\:\\ 0\\.008310921896135894\ \(0\)\
\-\ joseph\\:\\ 0\\.008240576457211667\ \(0\)\
\-\ 111\\/63\\:\\ 0\\.00821576740351025\ \(0\)\
\-\ 27\\.99\\.\\:\\ 0\\.00821576740351025\ \(0\)\
\-\ acute\\-phase\\:\\ 0\\.00821576740351025\ \(0\)\
\-\ vasoconstrictors\\:\\ 0\\.00821576740351025\ \(0\)\
\-\ methyl\\:\\ 0\\.00821576740351025\ \(0\)\
\-\ 10\\‚\\Ä\\ì25\\:\\ 0\\.00821576740351025\ \(0\)\
\-\ plasmapheresis\\:\\ 0\\.00821576740351025\ \(0\)\
\-\ campath\\-1h\\:\\ 0\\.00821576740351025\ \(0\)\
\-\ calado\\:\\ 0\\.00821576740351025\ \(0\)\
\-\ viana\\-baptista\\:\\ 0\\.00821576740351025\ \(0\)\
\-\ \\:201\\-12\\:\\ 0\\.00821576740351025\ \(0\)\
\-\ coefficient\\:\\ 0\\.00821576740351025\ \(0\)\
\-\ pseudoanyeurysm\\:\\ 0\\.00821576740351025\ \(0\)\
\-\ ailment\\:\\ 0\\.00821576740351025\ \(0\)\
\-\ \\/eclampsia\\:\\ 0\\.00821576740351025\ \(0\)\
\-\ imaging\\/angiography\\:\\ 0\\.00821576740351025\ \(0\)\
\-\ indium\\-labelled\\:\\ 0\\.00821576740351025\ \(0\)\
\-\ sausage\\:\\ 0\\.00821576740351025\ \(0\)\
\-\ singhal\\:\\ 0\\.00821576740351025\ \(0\)\
\-\ neurocrit\\:\\ 0\\.00821576740351025\ \(0\)\
\-\ \\:91\\-7\\:\\ 0\\.00821576740351025\ \(0\)\
\-\ wilhelm\\:\\ 0\\.00821576740351025\ \(0\)\
\-\ \\‚\\Ä\\ì190\\:\\ 0\\.00821576740351025\ \(0\)\
\-\ amos\\:\\ 0\\.00821576740351025\ \(0\)\
\-\ nurs\\:\\ 0\\.00821576740351025\ \(0\)\
\-\ \\:9\\-12\\:\\ 0\\.00821576740351025\ \(0\)\
\-\ nonspecific\\:\\ 0\\.008195112425293383\ \(0\)\
\-\ esr\\:\\ 0\\.00806501780845174\ \(0\)\
\-\ treatment\\:\\ 0\\.008059724881644394\ \(0\)\
\-\ angiography\\:\\ 0\\.008003224318578672\ \(0\)\
\-\ definitive\\:\\ 0\\.007866539746191814\ \(0\)\
\-\ vascular\\:\\ 0\\.007833559928957214\ \(0\)\
\-\ ischemic\\:\\ 0\\.007756865002439842\ \(0\)\
\-\ disorders\\:\\ 0\\.007620001128153136\ \(0\)\
\-\ vessel\\:\\ 0\\.0075872997122148145\ \(0\)\
\-\ xanthochromia\\:\\ 0\\.00756977748686538\ \(0\)\
\-\ antagonists\\:\\ 0\\.00756977748686538\ \(0\)\
\-\ mid\\-posterior\\:\\ 0\\.00756977748686538\ \(0\)\
\-\ 3\\:\\ 0\\.007459368226305833\ \(0\)\
\-\ medical\\:\\ 0\\.007351285554704579\ \(0\)\
\-\ diagnosis\\:\\ 0\\.0073148903290975575\ \(0\)\
\-\ amphetamines\\:\\ 0\\.007191897609784145\ \(0\)\
\-\ 34\\-year\\-old\\:\\ 0\\.007191897609784145\ \(0\)\
\-\ 184\\:\\ 0\\.007191897609784145\ \(0\)\
\-\ neurosci\\:\\ 0\\.007191897609784145\ \(0\)\
\-\ diffusion\\:\\ 0\\.007129703331198065\ \(0\)\
\-\ infarct\\:\\ 0\\.0070673586265055394\ \(0\)\
\-\ may\\:\\ 0\\.006987244618445941\ \(0\)\
\-\ life\\:\\ 0\\.006948596623921928\ \(0\)\
\-\ 97\\.6\\:\\ 0\\.00692378757022051\ \(0\)\
\-\ 158\\:\\ 0\\.00692378757022051\ \(0\)\
\-\ agree\\:\\ 0\\.00692378757022051\ \(0\)\
\-\ curr\\:\\ 0\\.00692378757022051\ \(0\)\
\-\ cardiovasc\\:\\ 0\\.00692378757022051\ \(0\)\
\-\ heroin\\:\\ 0\\.00692378757022051\ \(0\)\
\-\ bernstein\\:\\ 0\\.00692378757022051\ \(0\)\
\-\ neurological\\:\\ 0\\.006891937766169139\ \(0\)\
\-\ 2\\:\\ 0\\.006859662615137171\ \(0\)\
\-\ foci\\:\\ 0\\.006836950507275014\ \(0\)\
\-\ external\\:\\ 0\\.006773037975162001\ \(0\)\
\-\ right\\:\\ 0\\.006722324019462566\ \(0\)\
\-\ vasculopathy\\:\\ 0\\.006715825267038581\ \(0\)\
\-\ secondary\\:\\ 0\\.006679487324814932\ \(0\)\
\-\ references\\:\\ 0\\.006622233429751375\ \(0\)\
\-\ arteries\\:\\ 0\\.006593483252070794\ \(0\)\
\-\ treatable\\:\\ 0\\.006545907693139275\ \(0\)\
\-\ fitting\\:\\ 0\\.006545907693139275\ \(0\)\
\-\ vasoconstriction\\:\\ 0\\.006545907693139275\ \(0\)\
\-\ upon\\:\\ 0\\.00650980138830958\ \(0\)\
\-\ no\\:\\ 0\\.006415240638984544\ \(0\)\
\-\ vessels\\:\\ 0\\.006412376544794656\ \(0\)\
\-\ \\¬\\∞f\\:\\ 0\\.006402244431417693\ \(0\)\
\-\ azathioprine\\:\\ 0\\.006402244431417693\ \(0\)\
\-\ photon\\:\\ 0\\.006402244431417693\ \(0\)\
\-\ irregular\\:\\ 0\\.006352929454811518\ \(0\)\
\-\ made\\:\\ 0\\.006344589696386688\ \(0\)\
\-\ cocaine\\:\\ 0\\.0062777976535756405\ \(0\)\
\-\ pressure\\:\\ 0\\.006255233755493642\ \(0\)\
\-\ g1p1\\:\\ 0\\.006168027816058041\ \(0\)\
\-\ used\\:\\ 0\\.0061103152972003015\ \(0\)\
\-\ er\\:\\ 0\\.0061103152972003015\ \(0\)\
\-\ immunoglobulin\\:\\ 0\\.006069835350393711\ \(0\)\
\-\ nodosa\\:\\ 0\\.005981009460548115\ \(0\)\
\-\ a\\:\\ 0\\.005913883344918565\ \(0\)\
\-\ emission\\:\\ 0\\.005899917776494405\ \(0\)\
\-\ erythrocyte\\:\\ 0\\.005899917776494405\ \(0\)\
\-\ acute\\:\\ 0\\.005899010239813127\ \(0\)\
\-\ vasospasm\\:\\ 0\\.00582532065843892\ \(0\)\
\-\ flight\\:\\ 0\\.005756254514772823\ \(0\)\
\-\ takayasu\\:\\ 0\\.005756254514772823\ \(0\)\
\-\ brant\\:\\ 0\\.005756254514772823\ \(0\)\
\-\ otherwise\\:\\ 0\\.0057209976391916955\ \(0\)\
\-\ intracerebral\\:\\ 0\\.005691955473312477\ \(0\)\
\-\ 1\\:\\ 0\\.005684975865684176\ \(0\)\
\-\ biopsy\\:\\ 0\\.005650872770991166\ \(0\)\
\-\ weekly\\:\\ 0\\.005631807736930771\ \(0\)\
\-\ variation\\:\\ 0\\.005631807736930771\ \(0\)\
\-\ imaging\\:\\ 0\\.005597596899689476\ \(0\)\
\-\ international\\:\\ 0\\.00557530762340194\ \(0\)\
\-\ helms\\:\\ 0\\.005522037899413172\ \(0\)\
\-\ side\\:\\ 0\\.005518073628637597\ \(0\)\
\-\ small\\:\\ 0\\.005503938353348887\ \(0\)\
\-\ that\\:\\ 0\\.005502258074776601\ \(0\)\
\-\ mri\\:\\ 0\\.005489121681960727\ \(0\)\
\-\ 3d\\:\\ 0\\.005471649063187379\ \(0\)\
\-\ ht\\:\\ 0\\.005423845433748842\ \(0\)\
\-\ erythematosus\\:\\ 0\\.005423845433748842\ \(0\)\
\-\ elevated\\:\\ 0\\.005404131148851935\ \(0\)\
\-\ investigation\\:\\ 0\\.005378374637691589\ \(0\)\
\-\ contrast\\:\\ 0\\.005347928294896287\ \(0\)\
\-\ bmi\\:\\ 0\\.005335019543903245\ \(0\)\
\-\ authors\\:\\ 0\\.005335019543903245\ \(0\)\
\-\ 0\\.4\\:\\ 0\\.005335019543903245\ \(0\)\
\-\ sedimentation\\:\\ 0\\.005335019543903245\ \(0\)\
\-\ fundamentals\\:\\ 0\\.005335019543903245\ \(0\)\
\-\ vol\\:\\ 0\\.005335019543903245\ \(0\)\
\-\ spect\\:\\ 0\\.005293591992579076\ \(0\)\
\-\ sylvian\\:\\ 0\\.005293591992579076\ \(0\)\
\-\ tested\\:\\ 0\\.005293591992579076\ \(0\)\
\-\ feb\\:\\ 0\\.005293591992579076\ \(0\)\
\-\ channel\\:\\ 0\\.005253927859849536\ \(0\)\
\-\ linked\\:\\ 0\\.005253927859849536\ \(0\)\
\-\ w\\:\\ 0\\.005253927859849536\ \(0\)\
\-\ p\\.\\:\\ 0\\.005253927859849536\ \(0\)\
\-\ bilaterally\\:\\ 0\\.005231510230240267\ \(0\)\
\-\ worst\\:\\ 0\\.0052158831305669125\ \(0\)\
\-\ description\\:\\ 0\\.00517933074179405\ \(0\)\
\-\ opposed\\:\\ 0\\.005144158022331938\ \(0\)\
\-\ several\\:\\ 0\\.005120396711504916\ \(0\)\
\-\ wt\\:\\ 0\\.005110264598127953\ \(0\)\
\-\ carcinomas\\:\\ 0\\.005110264598127953\ \(0\)\
\-\ superior\\:\\ 0\\.005086195148283674\ \(0\)\
\-\ methotrexate\\:\\ 0\\.005077560665405427\ \(0\)\
\-\ autoimmune\\:\\ 0\\.005077560665405427\ \(0\)\
\-\ further\\:\\ 0\\.005065133535508403\ \(0\)\
\-\ looking\\:\\ 0\\.005045965556667607\ \(0\)\
\-\ cessation\\:\\ 0\\.0050154065419211104\ \(0\)\
\-\ lippincott\\:\\ 0\\.0050154065419211104\ \(0\)\
\-\ frontal\\:\\ 0\\.005003340045635335\ \(0\)\
\-\ 98\\:\\ 0\\.00492931770675707\ \(0\)\
\-\ gram\\:\\ 0\\.00492931770675707\ \(0\)\
\-\ lyme\\:\\ 0\\.00492931770675707\ \(0\)\
\-\ established\\:\\ 0\\.004876047982768302\ \(0\)\
\-\ scanning\\:\\ 0\\.004876047982768302\ \(0\)\
\-\ wilkins\\:\\ 0\\.004876047982768302\ \(0\)\
\-\ corticosteroids\\:\\ 0\\.004850513058082268\ \(0\)\
\-\ as\\:\\ 0\\.004818555473976245\ \(0\)\
\-\ patient\\:\\ 0\\.004789889641657342\ \(0\)\
\-\ basis\\:\\ 0\\.004777855517103972\ \(0\)\
\-\ modalities\\:\\ 0\\.004777855517103972\ \(0\)\
\-\ the\\:\\ 0\\.004767216713918131\ \(0\)\
\-\ sle\\:\\ 0\\.004754842830626459\ \(0\)\
\-\ benefit\\:\\ 0\\.004754842830626459\ \(0\)\
\-\ primary\\:\\ 0\\.004718330406142957\ \(0\)\
\-\ hypertensive\\:\\ 0\\.004710455086927246\ \(0\)\
\-\ prominence\\:\\ 0\\.004710455086927246\ \(0\)\
\-\ lupus\\:\\ 0\\.004689029627258375\ \(0\)\
\-\ williams\\:\\ 0\\.004689029627258375\ \(0\)\
\-\ demonstrated\\:\\ 0\\.004673662595446351\ \(0\)\
\-\ resonance\\:\\ 0\\.004668085679586373\ \(0\)\
\-\ 5\\:\\ 0\\.004660131262710462\ \(0\)\
\-\ projection\\:\\ 0\\.00462755901421849\ \(0\)\
\-\ treatments\\:\\ 0\\.004607937943204667\ \(0\)\
\-\ was\\:\\ 0\\.004605207466047002\ \(0\)\
\-\ lbs\\:\\ 0\\.0045887214593251366\ \(0\)\
\-\ rbc\\:\\ 0\\.0045887214593251366\ \(0\)\
\-\ 2006\\:\\ 0\\.0045887214593251366\ \(0\)\
\-\ med\\:\\ 0\\.004569893213922043\ \(0\)\
\-\ magnetic\\:\\ 0\\.004569893213922043\ \(0\)\
\-\ within\\:\\ 0\\.0045576833412472\ \(0\)\
\-\ sulci\\:\\ 0\\.004551437829675836\ \(0\)\
\-\ syndromes\\:\\ 0\\.004551437829675836\ \(0\)\
\-\ axial\\:\\ 0\\.004545743664618586\ \(0\)\
\-\ affects\\:\\ 0\\.00453334082514918\ \(0\)\
\-\ journal\\:\\ 0\\.004515588546518524\ \(0\)\
\-\ treat\\:\\ 0\\.004498168105687068\ \(0\)\
\-\ provide\\:\\ 0\\.004464274681483083\ \(0\)\
\-\ philadelphia\\:\\ 0\\.004464274681483083\ \(0\)\
\-\ ct\\:\\ 0\\.004455931606307709\ \(0\)\
\-\ 4\\:\\ 0\\.004437971864266627\ \(0\)\
\-\ females\\:\\ 0\\.004431570748760558\ \(0\)\
\-\ ruled\\:\\ 0\\.004431570748760558\ \(0\)\
\-\ 63\\:\\ 0\\.004415639310401471\ \(0\)\
\-\ an\\:\\ 0\\.004405088030884361\ \(0\)\
\-\ mg\\:\\ 0\\.004369416625276241\ \(0\)\
\-\ ra\\:\\ 0\\.0043545048439654855\ \(0\)\
\-\ branches\\:\\ 0\\.0043545048439654855\ \(0\)\
\-\ blood\\:\\ 0\\.004347457730679029\ \(0\)\
\-\ k\\:\\ 0\\.00433982790364103\ \(0\)\
\-\ cell\\:\\ 0\\.0043024057997790984\ \(0\)\
\-\ 2005\\:\\ 0\\.004297134953006088\ \(0\)\
\-\ lobe\\:\\ 0\\.004285788160155702\ \(0\)\
\-\ significant\\:\\ 0\\.004283032900380658\ \(0\)\
\-\ fissure\\:\\ 0\\.0042697221988529715\ \(0\)\
\-\ make\\:\\ 0\\.004256312378301154\ \(0\)\
\-\ probably\\:\\ 0\\.004243092774394392\ \(0\)\
\-\ ua\\:\\ 0\\.004230058066123432\ \(0\)\
\-\ signal\\:\\ 0\\.004199579366771256\ \(0\)\
\-\ evidence\\:\\ 0\\.0041760346381488865\ \(0\)\
\-\ dose\\:\\ 0\\.004167486488455558\ \(0\)\
\-\ african\\:\\ 0\\.004155460948067947\ \(0\)\
\-\ cta\\:\\ 0\\.004155460948067947\ \(0\)\
\-\ depending\\:\\ 0\\.004143588603447788\ \(0\)\
\-\ daily\\:\\ 0\\.004120288228605834\ \(0\)\
\-\ m\\:\\ 0\\.004108852913981589\ \(0\)\
\-\ nuclear\\:\\ 0\\.004108852913981589\ \(0\)\
\-\ anterior\\:\\ 0\\.004102130146808458\ \(0\)\
\-\ delivery\\:\\ 0\\.004086394804401849\ \(0\)\
\-\ leukemia\\:\\ 0\\.004086394804401849\ \(0\)\
\-\ standard\\:\\ 0\\.004075365486930271\ \(0\)\
\-\ rr\\:\\ 0\\.0040644651702823765\ \(0\)\
\-\ relief\\:\\ 0\\.0040644651702823765\ \(0\)\
\-\ on\\:\\ 0\\.00404785281844601\ \(0\)\
\-\ t2\\-weighted\\:\\ 0\\.00403250890422587\ \(0\)\
\-\ setting\\:\\ 0\\.004022095762941503\ \(0\)\
\-\ diseases\\:\\ 0\\.0040117976863463635\ \(0\)\
\-\ more\\:\\ 0\\.003983553232641502\ \(0\)\
\-\ need\\:\\ 0\\.0039717069267157104\ \(0\)\
\-\ help\\:\\ 0\\.0039717069267157104\ \(0\)\
\-\ characteristics\\:\\ 0\\.003961948026559797\ \(0\)\
\-\ in\\:\\ 0\\.003927280802798275\ \(0\)\
\-\ disease\\:\\ 0\\.0039051375802862187\ \(0\)\
\-\ increased\\:\\ 0\\.0038965233584336545\ \(0\)\
\-\ calcium\\:\\ 0\\.0038963554853092847\ \(0\)\
\-\ complaining\\:\\ 0\\.003887350908504311\ \(0\)\
\-\ right\\-sided\\:\\ 0\\.003887350908504311\ \(0\)\
\-\ hr\\:\\ 0\\.003878432501219921\ \(0\)\
\-\ options\\:\\ 0\\.0038695986298736547\ \(0\)\
\-\ subarachnoid\\:\\ 0\\.0038695986298736547\ \(0\)\
\-\ times\\:\\ 0\\.003860847706900831\ \(0\)\
\-\ highly\\:\\ 0\\.0038350774074315764\ \(0\)\
\-\ giant\\:\\ 0\\.0038350774074315764\ \(0\)\
\-\ catheter\\:\\ 0\\.0038266432643561644\ \(0\)\
\-\ american\\:\\ 0\\.0037936498561074073\ \(0\)\
\-\ infections\\:\\ 0\\.0037855808321156886\ \(0\)\
\-\ c\\:\\ 0\\.0037855808321156886\ \(0\)\
\-\ tissue\\:\\ 0\\.0037752491863049277\ \(0\)\
\-\ rheumatoid\\:\\ 0\\.0037617846513093834\ \(0\)\
\-\ therefore\\:\\ 0\\.0037617846513093834\ \(0\)\
\-\ steroids\\:\\ 0\\.00374625151758598\ \(0\)\
\-\ felt\\:\\ 0\\.00374625151758598\ \(0\)\
\-\ normal\\:\\ 0\\.003745421587881923\ \(0\)\
\-\ recently\\:\\ 0\\.003715940994095244\ \(0\)\
\-\ hemorrhagic\\:\\ 0\\.003715940994095244\ \(0\)\
\-\ 39\\:\\ 0\\.0037011475652450206\ \(0\)\
\-\ of\\:\\ 0\\.003691639540663194\ \(0\)\
\-\ and\\:\\ 0\\.0036907717857491205\ \(0\)\
\-\ t\\:\\ 0\\.0036865852932011422\ \(0\)\
\-\ like\\:\\ 0\\.0036865852932011422\ \(0\)\
\-\ be\\:\\ 0\\.0036843151631237537\ \(0\)\
\-\ deficits\\:\\ 0\\.003644215885860269\ \(0\)\
\-\ control\\:\\ 0\\.0036305102498959676\ \(0\)\
\-\ r\\:\\ 0\\.003617003253341851\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.003597102857749522\ \(0\)\
\-\ j\\:\\ 0\\.003597102857749522\ \(0\)\
\-\ healthy\\:\\ 0\\.0035905627154767853\ \(0\)\
\-\ \\‚\\Ä\\ì\\:\\ 0\\.0035840681494785625\ \(0\)\
\-\ distribution\\:\\ 0\\.0035840681494785625\ \(0\)\
\-\ medications\\:\\ 0\\.00355225733273163\ \(0\)\
\-\ worse\\:\\ 0\\.003527568035949732\ \(0\)\
\-\ necessary\\:\\ 0\\.003527568035949732\ \(0\)\
\-\ seizure\\:\\ 0\\.003521496571810689\ \(0\)\
\-\ apparent\\:\\ 0\\.003521496571810689\ \(0\)\
\-\ exam\\:\\ 0\\.003499038098694386\ \(0\)\
\-\ case\\:\\ 0\\.003484630816155211\ \(0\)\
\-\ needed\\:\\ 0\\.003468563115712708\ \(0\)\
\-\ bp\\:\\ 0\\.0034571975303503426\ \(0\)\
\-\ 18\\:\\ 0\\.0034571975303503426\ \(0\)\
\-\ four\\:\\ 0\\.0034571975303503426\ \(0\)\
\-\ enhanced\\:\\ 0\\.003407700955034454\ \(0\)\
\-\ arthritis\\:\\ 0\\.003402360158474356\ \(0\)\
\-\ findings\\:\\ 0\\.0033901900014724315\ \(0\)\
\-\ etiology\\:\\ 0\\.0033709425840640003\ \(0\)\
\-\ before\\:\\ 0\\.0033709425840640003\ \(0\)\
\-\ radiology\\:\\ 0\\.0033658077697014937\ \(0\)\
\-\ oral\\:\\ 0\\.003355622242644466\ \(0\)\
\-\ multiple\\:\\ 0\\.0033547176206510138\ \(0\)\
\-\ best\\:\\ 0\\.0033505709216105997\ \(0\)\
\-\ condition\\:\\ 0\\.003330635050239381\ \(0\)\
\-\ pa\\:\\ 0\\.003330635050239381\ \(0\)\
\-\ csf\\:\\ 0\\.0033257170100708406\ \(0\)\
\-\ amount\\:\\ 0\\.0033257170100708406\ \(0\)\
\-\ history\\:\\ 0\\.003299761056030988\ \(0\)\
\-\ located\\:\\ 0\\.0032779133806323034\ \(0\)\
\-\ occurs\\:\\ 0\\.003268640006118633\ \(0\)\
\-\ single\\:\\ 0\\.0032280151821905234\ \(0\)\
\-\ includes\\:\\ 0\\.003210512950455578\ \(0\)\
\-\ typical\\:\\ 0\\.0031933333589468753\ \(0\)\
\-\ currently\\:\\ 0\\.003155799436171535\ \(0\)\
\-\ diagnostic\\:\\ 0\\.003155799436171535\ \(0\)\
\-\ aneurysm\\:\\ 0\\.0031476599394625374\ \(0\)\
\-\ hypertension\\:\\ 0\\.0031395909154708183\ \(0\)\
\-\ rate\\:\\ 0\\.0031041206807789776\ \(0\)\
\-\ rare\\:\\ 0\\.0030925910518856442\ \(0\)\
\-\ developed\\:\\ 0\\.0030662306475626416\ \(0\)\
\-\ classic\\:\\ 0\\.0030514956932041677\ \(0\)\
\-\ headaches\\:\\ 0\\.003044214668286373\ \(0\)\
\-\ management\\:\\ 0\\.0030051551197163478\ \(0\)\
\-\ commonly\\:\\ 0\\.0030051551197163478\ \(0\)\
\-\ throughout\\:\\ 0\\.002981125187604778\ \(0\)\
\-\ 8\\:\\ 0\\.0029777423655632323\ \(0\)\
\-\ studies\\:\\ 0\\.0029743717779861694\ \(0\)\
\-\ mm\\:\\ 0\\.0029284204629962773\ \(0\)\
\-\ middle\\:\\ 0\\.0029125433081476585\ \(0\)\
\-\ care\\:\\ 0\\.00287248569158318\ \(0\)\
\-\ weight\\:\\ 0\\.0028545627074938167\ \(0\)\
\-\ typically\\:\\ 0\\.0028112076137054728\ \(0\)\
\-\ or\\:\\ 0\\.00280015680045771\ \(0\)\
\-\ labs\\:\\ 0\\.0027697800623813027\ \(0\)\
\-\ benign\\:\\ 0\\.002748415999098976\ \(0\)\
\-\ for\\:\\ 0\\.002718017329516179\ \(0\)\
\-\ cause\\:\\ 0\\.0026945597637949357\ \(0\)\
\-\ although\\:\\ 0\\.0026895892642838804\ \(0\)\
\-\ this\\:\\ 0\\.0026872429076816398\ \(0\)\
\-\ 10\\:\\ 0\\.002684645133594511\ \(0\)\
\-\ first\\:\\ 0\\.0026723983548796386\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.002650751709390527\ \(0\)\
\-\ white\\:\\ 0\\.0026412900398061676\ \(0\)\
\-\ out\\:\\ 0\\.0026319234639874335\ \(0\)\
\-\ study\\:\\ 0\\.002620346092134165\ \(0\)\
\-\ past\\:\\ 0\\.002530474810760889\ \(0\)\
\-\ known\\:\\ 0\\.002520084887664324\ \(0\)\
\-\ found\\:\\ 0\\.0025098095195266656\ \(0\)\
\-\ such\\:\\ 0\\.0024895925348004215\ \(0\)\
\-\ image\\:\\ 0\\.002487594749578379\ \(0\)\
\-\ during\\:\\ 0\\.0024371008852971184\ \(0\)\
\-\ some\\:\\ 0\\.002418386070705274\ \(0\)\
\-\ to\\:\\ 0\\.002388078891573083\ \(0\)\
\-\ treated\\:\\ 0\\.00238383116130835\ \(0\)\
\-\ artery\\:\\ 0\\.002371416581647902\ \(0\)\
\-\ not\\:\\ 0\\.0023016191458377173\ \(0\)\
\-\ syndrome\\:\\ 0\\.0022776389345150433\ \(0\)\
\-\ appearance\\:\\ 0\\.0022776389345150433\ \(0\)\
\-\ lymphoma\\:\\ 0\\.0022760471895521767\ \(0\)\
\-\ focal\\:\\ 0\\.0022744581585632823\ \(0\)\
\-\ head\\:\\ 0\\.0022587151077109935\ \(0\)\
\-\ edema\\:\\ 0\\.002252491602452275\ \(0\)\
\-\ time\\:\\ 0\\.0022493953655538792\ \(0\)\
\-\ high\\:\\ 0\\.0021794464688507133\ \(0\)\
\-\ months\\:\\ 0\\.002175154981071824\ \(0\)\
\-\ are\\:\\ 0\\.0021712467335127713\ \(0\)\
\-\ presented\\:\\ 0\\.0021708831640469797\ \(0\)\
\-\ been\\:\\ 0\\.002166630838270262\ \(0\)\
\-\ enhancement\\:\\ 0\\.002134658682314106\ \(0\)\
\-\ is\\:\\ 0\\.002096144560614075\ \(0\)\
\-\ who\\:\\ 0\\.0020763918072150066\ \(0\)\
\-\ both\\:\\ 0\\.002033737176781101\ \(0\)\
\-\ symptoms\\:\\ 0\\.001984769316773662\ \(0\)\
\-\ associated\\:\\ 0\\.001879275453781642\ \(0\)\
\-\ most\\:\\ 0\\.001838616161908738\ \(0\)\
\-\ demonstrate\\:\\ 0\\.0018326674196952849\ \(0\)\
\-\ can\\:\\ 0\\.001806358203605843\ \(0\)\
\-\ left\\:\\ 0\\.0017821160657463461\ \(0\)\
\-\ large\\:\\ 0\\.0017414188553877723\ \(0\)\
\-\ lateral\\:\\ 0\\.0017210326613462724\ \(0\)\
\-\ but\\:\\ 0\\.0016985119301337723\ \(0\)\
\-\ female\\:\\ 0\\.0016372416322906185\ \(0\)\
\-\ presents\\:\\ 0\\.001626881915664423\ \(0\)\
\-\ also\\:\\ 0\\.0015700089409787057\ \(0\)\
\-\ images\\:\\ 0\\.001527738948694645\ \(0\)\
\-\ \\.\\:\\ 0\\.0015218813238377714\ \(0\)\
\-\ has\\:\\ 0\\.0014955265335454594\ \(0\)\
\-\ which\\:\\ 0\\.0014866212369455253\ \(0\)\
\-\ by\\:\\ 0\\.0013260679433782616\ \(0\)\
\-\ there\\:\\ 0\\.0011851962315610333\ \(0\)\
\-\ with\\:\\ 0\\.0009813956987968385\ \(0\)\
